Year: 2006
Type: dissertation
Abstract: The vertebrate immune system, that controls host defense against infectious diseases, can be divided into innate and acquired immunity.In the traditional view of immunology, far less attention has been directed towards innate immunity, because it has been regarded as relatively nonspecific system, with its main roles being to destroy pathogens and to present antigen to the cells involved in acquired immunity.By contrast, acquired immunity has attracted lots of attention, as it has highly sophisticated system with specificity and diversity of antigen detection and immune memory, that is mediated by T and B cells.However, recent studies have shown that innate immunity also has the ability to discriminate between self and foreign pathogens and initiate host defense responses.In 1996, it has been shown that Toll, a receptor that is expressed by insects, has an essential role in the innate immune response against fungal infection in Drosophila, which only has innate immunity.Subsequent studies discovered Toll-like receptors (TLRs), the mammalian homologues of Toll.So far, 11 members of TLR family have been identified and are expressed in a wide range of cells, such as dendritic cells, macrophages and epithelial cells.TLRs recognize microbial components and activating signaling pathways, such as NF-κB, that induce the expression of immune and pro-inflammatory genes.In addition, recent studies have provided important clues about the mechanisms of TLR-mediated initiation of acquired immunity by inducing the inflammatory cytokines and costimulatory molecules in dendritic cells.Thus, TLR activation is essential for not only provoking the innate immune responses and inflammation, but also initiating the acquired immunity.However, TLRs have also been shown to be involved in the pathogenesis of autoimmune, chronic inflammatory and infectious diseases.Therefore, to avoid detrimental and inappropriate inflammatory responses, TLR signaling must be tightly regulated.In the present study, we focused the tumor suppressor cylindromatosis (CYLD), which has been shown to inhibit activation of the transcription factor NF-κB.CYLD gene was originally identified as a tumor suppressor that is mutated in familial cylindromatosis, an autosomal dominant predisposition to multiple tumors of the skin appendages.Recent studies reveal that CYLD is a new deubiquitinating enzyme that negatively regulates NF-κB activation by tumor-necrosis factor receptorassociated factors (TRAFs).Loss of the deubiquitinating activity of CYLD induces increased or prolonged activation of NF-κB that is important in the generation and growth of cylindromatisis.However, the role of CYLD in regulating innate immune responses and TLR signaling remains poorly defined.Here, we showed that CYLD inhibited NF-κB activation and TNF-α, IL-1β and IL-8 expression induced by TLR2 lignads including peptidoglycan (PGN), MALP-2 and Pam3CSK4 in HEK293-TLR2 cells.Furthermore, CYLD inhibited not only IKKs-IκBα-NF-κB pathway, but also MKK3/6-p38 MAPK pathway, both of which contributed the NF-κB activation and cytokines expression.We also found that both TRAF6 and TRAF7, a recently identified novel TRAF family member, are involved in TLR2 signaling.And, we suggested that CYLD inhibited TLR2 signaling via negative crosstalk with both TRAF6 and TRAF7 likely in a deubiquitinationdependent manner.Finally, we showed that CYLD itself was induced by TLR2 signaling.This finding thus unveil a novel autoregulatory feedback mechanism of TLR2 signaling.The present studies might lead to novel therapeutic approaches for autoimmune and chronic inflammatory diseases.
Author: Yoshida, Hiroki
Language: Japanese
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: CYLD, tumor suppressor, TLR2, TLR2 signaling, NF-κB activation, deubiquitinase, TRAF, innate immunity, tumor suppression, familial cylindromatosis, inflammation regulation, autoimmunity, chronic inflammation, infectious diseases, dendritic cells, macrophages, epithelial cells, costimulatory molecules, inflammatory cytokines
Open Access status: green
OpenAlex ID: W7146489706
